Molecules/IBALIZUMAB

IBALIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2018

Mechanism of action: T-cell surface antigen CD4 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

HU5A8IBALIZUMABIBALIZUMAB-UIYKTNX-355Trogarzo

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to IBALIZUMAB

Loading drug network...